Javier G. Blanco, associate professor in the UB School of Pharmacy and Pharmaceutical Sciences, received a $400,000 grant from the NICHD to investigate how therapeutic antibodies are handled in the human lung.
Rina Das Eiden, senior research scientist in UB’s Research Institute on Addictions, has been named chair of the Psychosocial Development, Risk and Prevention Study Section in the NIH’s Center for Scientific Review.
UB President Satish K. Tripathi and RPCI President and CEO Candace Johnson today strongly urged members of the Western New York congressional delegation to resist a Trump administration budget proposal to cap federal spending on costs essential to conducting research.
Ask Elizabeth Bowen about the intersection of homelessness and HIV/AIDS in the United States and she’ll respond without hesitation, “Housing equals health.”
Twenty-four of the best and brightest regional companies have been selected to participate in the University at Buffalo’s Bright Buffalo Niagara Entrepreneur Expo on June 28 at the Hotel Henry.
One study will look at the barriers to PrEP usage through interviews with patients and clinicians, while the other will investigate a less invasive method for measuring PrEP adherence.
A UB-led team of researchers found that combinations of three antibiotics – that are each ineffective against superbugs when used alone – are capable of eradicating two of the six ESKAPE pathogens when delivered together.